Affle (India) Limited vs Sun Pharmaceutical Industries Limited
Put two companies head-to-head — source-verified financials and AI-analysed SWOT, together in one view.
Affle (India) Limited (Advertising technology) and Sun Pharmaceutical Industries Limited (Pharmaceuticals) go head-to-head here — with source-verified financials and a full SWOT breakdown side by side on Nexvora Intelligence. On the figures reported, Affle (India) Limited leads on Revenue (approx.).
Affle (India) Limited leads on Revenue (approx.).
Head-to-head highlights
| Metric | Affle (India) Limited | Sun Pharmaceutical Industries Limited | Basis |
|---|---|---|---|
| Revenue (approx.) | Approximately ₹1,800-1,900 crore | Approximately INR 480-490 billion | AI estimate |
An arrow marks the larger reported figure — a factual comparison, not a quality judgement. Verified figures come from official filings; AI estimates are approximate and unverified.
Affle (India) Limited
Advertising technology · India
Affle (India) Limited is an Indian advertising technology company focused on mobile marketing, user acquisition, and consumer intelligence. Its platforms help advertisers acquire, engage, and monetize users across mobile apps and digital channels, with a strong focus on India and other emerging markets.
Verified financials
No source-verified financials available.
Strengths
- Strong mobile-first adtech specialization
- Performance-based advertising model aligned with advertiser ROI
- Presence across India, Southeast Asia, and other growth markets
- Portfolio expanded through acquisitions such as Jampp, mediasmart, and RevX
Weaknesses
- Smaller scale than global platform giants
- Dependence on mobile advertising budgets
- Business complexity from multiple acquired platforms
- Exposure to margin pressure in competitive performance marketing
Opportunities
- Growth in mobile app ecosystems across emerging markets
- Rising advertiser demand for measurable performance marketing
- Expansion of AI-driven campaign optimization and consumer intelligence
- Cross-selling across acquired adtech platforms
Threats
- Privacy regulation and mobile identifier restrictions
- Competition from large walled-garden platforms
- Ad fraud and brand-safety concerns in digital advertising
- Macroeconomic slowdowns affecting advertising spend
Sun Pharmaceutical Industries Limited
Pharmaceuticals · India
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company that develops, manufactures, and markets generic, branded generic, specialty, and over-the-counter medicines. It has a significant presence in India, the United States, and other international markets across therapies such as dermatology, ophthalmology, oncology, cardiology, and neurology.
Verified financials
No source-verified financials available.
Strengths
- Large global manufacturing and distribution footprint
- Strong position in Indian branded generics
- Diversified portfolio across therapies and geographies
- Growing specialty pharmaceuticals business
- Established R&D and regulatory capabilities
Weaknesses
- Exposure to U.S. generic drug pricing pressure
- Regulatory compliance risk across multiple manufacturing sites
- Dependence on successful specialty drug commercialization
- Complex integration and operational oversight due to global scale
Opportunities
- Expansion of specialty and innovative medicines portfolio
- Growth in emerging pharmaceutical markets
- Increased demand for affordable generics globally
- Potential acquisitions or licensing deals in specialty therapies
- Expansion in dermatology, ophthalmology, and oncology
Threats
- Intense competition in generics
- Regulatory actions or import restrictions
- Patent litigation and intellectual property disputes
- Currency volatility and pricing controls
- Supply chain disruptions and raw material cost increases
Frequently asked
Answered from source-verified figures on this page.
Affle (India) Limited vs Sun Pharmaceutical Industries Limited: which company leads overall?
Affle (India) Limited leads on Revenue (approx.).
AI Analyst
Insights and answers generated live from Affle (India) Limited vs Sun Pharmaceutical Industries Limited's verified data. Modeled estimates — not investment advice.